METALYSE Side Effects

6589013-1 |
on Feb 09, 2010 Male patient from GERMANY , 19 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Metalyse (View Usage). . Metalyse dosage: .

6532093-X | Coronary Artery Occlusion
Patient was taking Metalyse (View Usage). Patient had the following side effects: coronary artery occlusion on Dec 26, 2009 from GERMANY Additional patient health information: Female patient , 56 years of age, was diagnosed with acute myocardial infarction and. Metalyse dosage: 40 Mg, Unk.

6530438-8 | Coronary Artery Occlusion
Adverse event was reported on Dec 26, 2009 by a Male patient taking Metalyse (View Usage) (Dosage: Unk) was diagnosed with acute myocardial infarction and. Location: GERMANY , 65 years of age, After Metalyse was administered, patient had the following side effects: coronary artery occlusion.

6474378-1 | Cardiac Arrest, Hepatic Rupture, Intra-abdominal Haemorrhage, Splenic Rupture
on Nov 24, 2009 Female patient from GERMANY , 49 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Metalyse (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hepatic rupture, intra-abdominal haemorrhage, splenic rupture. Metalyse dosage: 8000 U, Single.


6472367-4 | Myocardial Infarction
on Nov 27, 2009 Female patient from INDIA , 70 years of age, weighting 189.6 lb, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). Patient had the following side effects: myocardial infarction. Metalyse dosage: 40 Mg, Unk. During the same period patient was treated with HEPARIN (Unk) (View Heparin Review and Heparin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6454868-8 | Intermittent Claudication, Peripheral Embolism
Patient was taking Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: intermittent claudication, peripheral embolism on Nov 13, 2009 from GERMANY Additional patient health information: Male patient , 31 years of age, was diagnosed with thrombosis and. Metalyse dosage: 6000 U, X1. During the same period patient was treated with ACENOCOUMAROL (Unk) (View Acenocoumarol Review and Acenocoumarol Label ).

6432670-0 | Cerebral Haematoma, Cerebral Haemorrhage, Headache
Adverse event was reported on Oct 30, 2009 by a Female patient taking Metalyse (View Usage) (Dosage: Unk) was diagnosed with thrombolysis and. Location: GERMANY , 56 years of age, Patient experienced the following unwanted or unexpected effects: cerebral haematoma, cerebral haemorrhage, headache (What is headache?). Patient was hospitalized.

6425632-0 |
on Oct 28, 2009 Male patient from SINGAPORE , 60 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: 0.5 Mg/kg, Unk. Patient was hospitalized.

6425161-4 |
on Oct 28, 2009 Male patient from SINGAPORE , 92 years of age, was diagnosed with acute myocardial infarction, diabetes mellitus, hypertension and was treated with Metalyse (View Usage). . Metalyse dosage: 0.5 Mg/kg, Unk. During the same period patient was treated with ORAL HYPOGLYCEMIC (Unk) (View Oral Hypoglycemic Review and Oral Hypoglycemic Label ), ANTI HYPERTENSIVE MEDS (Unk) (View Anti Hypertensive Meds Review and Anti Hypertensive Meds Label ).

6327601-8 |
Patient was taking Metalyse (View Usage). on Aug 18, 2009 from GERMANY Additional patient health information: Male patient , 60 years of age, was diagnosed with myocardial infarction and. Metalyse dosage: Unk.

6305529-7 | Cardiac Arrest
Adverse event was reported on Aug 05, 2009 by a Male patient taking Metalyse (View Usage) (Dosage: 35 Mg, Unk) was diagnosed with acute myocardial infarction and. Location: GERMANY , 70 years of age, weighting 154.3 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?).

6247966-5 | Cardiogenic Shock
on Jun 20, 2009 Female patient from SINGAPORE , 75 years of age, weighting 132.3 lb, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: cardiogenic shock. Metalyse dosage: 30 Mg, Unk. During the same period patient was treated with HEPARIN (Unk) (View Heparin Review and Heparin Label ).

6222467-9 |
on May 27, 2009 Male patient from MEXICO , 72 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: Unk.

6190568-X |
Patient was taking Metalyse (View Usage). on May 05, 2009 from INDIA Additional patient health information: Male patient , 60 years of age, was diagnosed with acute myocardial infarction and. Metalyse dosage: 40 Mg, Unk.

6127988-5 |
Adverse event was reported on Mar 14, 2009 by a Female patient taking Metalyse (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: SINGAPORE , 80 years of age, .

6115624-3 |
on Mar 06, 2009 Female patient from SINGAPORE , 76 years of age, weighting 132.3 lb, was diagnosed with myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: 30 Mg, Unk. During the same period patient was treated with LOW MOLECULAR WT HEPARIN (Unk) (View Low Molecular Wt Heparin Review and Low Molecular Wt Heparin Label ).

6069437-1 |
on Jan 29, 2009 Female patient from AUSTRALIA , weighting 220.5 lb, was diagnosed with acute myocardial infarction, thrombolysis and was treated with Metalyse (View Usage). . Metalyse dosage: 50 Mg, Unk.

6051879-1 | Cardiac Arrest, Ventricular Fibrillation
Patient was taking Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), ventricular fibrillation on Jan 20, 2009 from NEW ZEALAND Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with myocardial infarction, cardiogenic shock and. Metalyse dosage: 40 Mg, Unk.

6033383-X |
Adverse event was reported on Jan 05, 2009 by a Male patient taking Metalyse (View Usage) (Dosage: 40 Mg, Unk) was diagnosed with acute myocardial infarction and. Location: INDIA , 55 years of age, .

6029176-X |
on Dec 29, 2008 Male patient from GERMANY , 54 years of age, was diagnosed with myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: 40 Mg, Unk.

6011371-7 |
on Dec 10, 2008 Female patient from AUSTRALIA , 70 years of age, was treated with Metalyse (View Usage). . Metalyse dosage: Unk.

5947536-X | Vascular Pseudoaneurysm
Patient was taking Metalyse (View Usage). Patient experienced the following unwanted or unexpected effects: vascular pseudoaneurysm on Nov 04, 2008 from GERMANY Additional patient health information: Female patient , 94 years of age, was diagnosed with ischaemic stroke, blood pressure decreased and. Metalyse dosage: Unk. During the same period patient was treated with PHENYLEPHRINE (Unk) (View Phenylephrine Review and Phenylephrine Label ).

5939364-6 | Haematoma, Haematuria
Adverse event was reported on Oct 30, 2008 by a Male patient taking Metalyse (View Usage) (Dosage: ) was diagnosed with thrombolysis and. Location: , weighting 141.1 lb, Patient had the following side effects: haematoma, haematuria. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (100mg) (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SERETIDE (View Seretide Review and Seretide Label ), LANSOPRAZOLE (30mg) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

5937770-7 | Chest Pain, Electrocardiogram St Segment Elevation
on Oct 22, 2008 Male patient from NEW ZEALAND , 67 years of age, was diagnosed with electrocardiogram st segment elevation and was treated with Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: chest pain (What is chest pain?), electrocardiogram st segment elevation. Metalyse dosage: Unk. Patient was hospitalized.

5884385-5 |
on Sep 11, 2008 Female patient from KOREA, REPUBLIC OF , 72 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: Unk. Patient was hospitalized.

5857228-3 |
Patient was taking Metalyse (View Usage). on Aug 20, 2008 from INDIA Additional patient health information: Female patient , 70 years of age, was diagnosed with acute myocardial infarction and. Metalyse dosage: 40 Mg, Unk. During the same period patient was treated with ENOXAPARIN SODIUM (Unk) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

5831074-9 |
Adverse event was reported on Jul 29, 2008 by a Male patient taking Metalyse (View Usage) (Dosage: 40 Mg, Unk) was diagnosed with acute myocardial infarction and. Location: INDIA , 61 years of age, .

5793947-5 |
on Jun 24, 2008 Male patient from SINGAPORE , 70 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: 35 Mg, Unk.

5725420-4 |
on Apr 28, 2008 Male patient from INDIA , 80 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). . Metalyse dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5615806-0 | Cardiac Arrest
Patient was taking Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Jan 28, 2008 from INDIA Additional patient health information: Male patient , 67 years of age, was diagnosed with acute myocardial infarction and. Metalyse dosage: 0.5 Mg/kg, Unk. During the same period patient was treated with HEPARIN (30 Mg, Unk) (View Heparin Review and Heparin Label ).

5610948-8 | Cardiac Arrest
Adverse event was reported on Jan 28, 2008 by a Male patient taking Metalyse (View Usage) (Dosage: 0.5 Mg/kg, Unk) was diagnosed with acute myocardial infarction and. Location: INDIA , 67 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with HEPARIN (30 Mg, Unk) (View Heparin Review and Heparin Label ).

5587547-X | Cardiac Arrest
on Jan 03, 2008 Male patient from SINGAPORE , 67 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Metalyse dosage: 40 Mg, Unk. During the same period patient was treated with HEPARIN (30 Mg, Unk) (View Heparin Review and Heparin Label ).

5548606-0 | Cardiac Arrest
on Dec 10, 2007 Male patient from SINGAPORE , 67 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Metalyse dosage: 40 Mg, Unk.

5534849-9 | Bradycardia, Cardiac Arrest
Patient was taking Metalyse (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?) on Nov 16, 2007 from GERMANY Additional patient health information: Male patient , 61 years of age, weighting 209.4 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Metalyse dosage: 150 Mg, Unk.

5491517-X | Acute Coronary Syndrome, Acute Myocardial Infarction, Alanine Aminotransferase Increased, Areflexia, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Lactic Acid Increased, Blood Pressure Decreased, Brain Compression
Adverse event was reported on Oct 15, 2007 by a Male patient taking Metalyse (View Usage) (Dosage: 9000 Iu, Once/single) was diagnosed with acute myocardial infarction and. Location: FRANCE , 46 years of age, Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, alanine aminotransferase increased, areflexia, aspartate aminotransferase increased, blood albumin decreased, blood lactic acid increased, blood pressure decreased, brain compression. During the same period patient was treated with LOVENOX (3 Mg, Once/single) (View Lovenox Review and Lovenox Label ), ASPEGIC 325 (250 Mg, Once/single) (View Aspegic 325 Review and Aspegic 325 Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), PLAVIX (1 Df, Qd) (View Plavix Review and Plavix Label ), SECTRAL (200 Mg, Bid) (View Sectral Review and Sectral Label ), AMLOR (5 Mg, Qd) (View Amlor Review and Amlor Label ), FOZITEC (10 Mg, Qd) (View Fozitec Review and Fozitec Label ), LESCOL (80 Mg, Qd) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5487170-1 | Cardiac Arrest
on Oct 10, 2007 Male patient from SINGAPORE , 67 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Metalyse dosage: 40 Mg, Unk.

5482308-4 | Circulatory Collapse
on Oct 08, 2007 Male patient from SINGAPORE , 67 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse. Metalyse dosage: 40 Mg, Unk.

5407106-9 | Myocardial Infarction
Patient was taking Metalyse (View Usage). Patient had the following side effects: myocardial infarction on Jul 31, 2007 from SINGAPORE Additional patient health information: Male patient , 84 years of age, was diagnosed with acute myocardial infarction and. Metalyse dosage: 40 Mg, 30 Mg As Iv Bolus. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

5402413-8 |
Adverse event was reported on Jul 24, 2007 by a Male patient taking Metalyse (View Usage) (Dosage: 40 Mg, 30 Mg As Iv Bolus) . Location: SINGAPORE , 84 years of age, . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

5395711-8 |
on Jul 19, 2007 Female patient from KOREA, REPUBLIC OF , 58 years of age, was diagnosed with cardio-respiratory arrest and was treated with Metalyse (View Usage). . Metalyse dosage: .

5395643-5 | Infarction
on Jul 20, 2007 Male patient from KOREA, REPUBLIC OF , 73 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). Patient had the following side effects: infarction. Metalyse dosage: 35 Mg, Unk.

5226773-6 |
Patient was taking Metalyse (View Usage). on Jan 27, 2007 from NEW ZEALAND Additional patient health information: Male patient , 56 years of age, was diagnosed with myocardial infarction and. Metalyse dosage: . During the same period patient was treated with DOPAMINE (DOPAMINE HYDROCHLORIDE) (View Dopamine (dopamine Hydrochloride) Review and Dopamine (dopamine Hydrochloride) Label ), TIROFIBAN (TIROFIBAN HYDROCHLORIDE) (View Tirofiban (tirofiban Hydrochloride) Review and Tirofiban (tirofiban Hydrochloride) Label ).

5218562-3 |
Adverse event was reported on Jan 18, 2007 by a Female patient taking Metalyse (View Usage) (Dosage: ) was diagnosed with thrombolysis and. Location: GERMANY , 86 years of age, .

5197258-0 | Angina Pectoris
on Dec 20, 2006 Female patient from GREECE , 65 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). Patient had the following side effects: angina pectoris. Metalyse dosage: 6000 Iu, Single, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BETA BLOCKERS (BETA BLOCKERS NOS) (View Beta Blockers (beta Blockers Nos) Review and Beta Blockers (beta Blockers Nos) Label ), NITRATES NOS (NITRATES NOS) (View Nitrates Nos (nitrates Nos) Review and Nitrates Nos (nitrates Nos) Label ), DIURETICS (DIURETICS) (View Diuretics (diuretics) Review and Diuretics (diuretics) Label ), ACE INHIBITOR (ANGIOTENSIN CONVERTING ENZYME INHIBITORS) (View Ace-inhibitor (angiotensin-converting Enzyme Inhibitors) Review and Ace-inhibitor (angiotensin-converting Enzyme Inhibitors) Label ), STATINS NOS (STATINS NOS) (View Statins Nos (statins Nos) Review and Statins Nos (statins Nos) Label ).

5196379-6 | Cerebral Haemorrhage
on Dec 15, 2006 Female patient from GERMANY , 72 years of age, was diagnosed with myocardial infarction and was treated with Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: cerebral haemorrhage. Metalyse dosage: Unk, Single, Intravenous. During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), MORPHINE (View Morphine Review and Morphine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

5189983-2 | Pancreatitis Haemorrhagic
Patient was taking Metalyse (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis haemorrhagic on Dec 08, 2006 from GERMANY Additional patient health information: Female patient , 52 years of age, . Metalyse dosage: Single, Intravenous.

5175148-7 |
Adverse event was reported on Nov 22, 2006 by a Male patient taking Metalyse (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: GERMANY , 56 years of age, . During the same period patient was treated with DOPAMINE (DOPAMINE HYDROCHLORIDE) (View Dopamine (dopamine Hydrochloride) Review and Dopamine (dopamine Hydrochloride) Label ), TIROFIBAN (TIROFIBAN HYDROCHLORIDE) (View Tirofiban (tirofiban Hydrochloride) Review and Tirofiban (tirofiban Hydrochloride) Label ).

5167317-7 | Angina Pectoris
on Nov 15, 2006 Female patient from GERMANY , 65 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse (View Usage). After Metalyse was administered, patient had the following side effects: angina pectoris. Metalyse dosage: 6000 Iu, Single, Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BETA BLOCKERS (BETA BLOCKERS NOS) (View Beta Blockers (beta Blockers Nos) Review and Beta Blockers (beta Blockers Nos) Label ), NITRATES NOS (NITRATES NOS) (View Nitrates Nos (nitrates Nos) Review and Nitrates Nos (nitrates Nos) Label ), DIURETICS (DIURETISC) (View Diuretics (diuretisc) Review and Diuretics (diuretisc) Label ), ACE INHIBITOR (ANGIOTENSIN CONVERTING ENZYME INHIBITORS) (View Ace-inhibitor (angiotensin-converting Enzyme Inhibitors) Review and Ace-inhibitor (angiotensin-converting Enzyme Inhibitors) Label ), STATINS NOS (STATINS NOS) (View Statins Nos (statins Nos) Review and Statins Nos (statins Nos) Label ).

5113442-6 |
on Sep 08, 2006 Female patient from AUSTRALIA , 86 years of age, was diagnosed with thrombolysis and was treated with Metalyse (View Usage). . Metalyse dosage: .